SHSE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 04/30/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeSHSE
Market Capitalization12,862 mln
Float560 mln
EPS
0.54
Moderate
P / E
17.76
Moderately valued
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.2
Caution advised
Relative Strength
25
/ 100
Underperforming
Debt / Equity
0.00
Debt-free
Business Description
Founded in 1996 and headquartered in Shanghai, China, Shanghai Shyndec Pharmaceutical Co. Ltd. researches, manufactures, and sells a broad range of medicines across multiple therapeutic areas. Its product portfolio spans antibiotics, cardiovascular treatments, neurological drugs, anti-inflammatory medications, and specialty compounds, serving patients throughout China. The company also produces active pharmaceutical ingredients and other materials that support the wider drug manufacturing industry.
